Neural Correlates of Depressive Symptoms in Smokers – A Systematic Review of Imaging Studies

ABSTRACT This review aims to summarize neuroimaging studies in order to better understand the neural correlates of depressive symptoms in tobacco smokers. Using the keywords “depressive OR depression” AND “tobacco OR nicotine OR smok* OR cigarette” AND “neuroimage OR magnetic resonance OR smri OR structural magnetic resonance OR fmri OR functional magnetic resonance OR pet OR positron emission tomography”, literature search was conducted in PubMed, Web of Science and PsycINFO databases. The first and the last author read the abstracts of all the studies found in the search (n = 179). The inclusion and exclusion criteria were applied and 150 articles were excluded. Then, both authors assessed the remaining 29 studies for eligibility and 16 studies were included in the present review. In the phase of active/chronic smoking, depressive symptoms are characterized as comorbidity related to an enhancement of dopamine release, and smokers have decreased Monoamine oxidase A (MAO-A). Stimuli-related functional magnetic resonance imaging (Stimuli-fMRI) studies also show that there is a positive correlation between the level of depressive symptoms and a greater response to general negative stimuli in active/chronic smokers. In the withdrawal phase, depressive symptoms are related to the withdrawal syndrome and increased MAO-A. Stimuli-fMRI studies show that there is a negative correlation between level of depressive symptoms and reactivity to negative stimuli in recent abstinent smokers. Major areas of the reward system such as the striatum and areas related to impulse control are activated to a greater extent in depressive smokers compared to non-depressed smokers.

[1]  Joseph P. Schacht,et al.  Neural substrates of cue reactivity: association with treatment outcomes and relapse , 2016, Addiction biology.

[2]  L. Mercer,et al.  Web-Based Acceptance and Commitment Therapy Smoking Cessation Treatment for Smokers With Depressive Symptoms , 2015, Journal of dual diagnosis.

[3]  J. Castaldelli-Maia,et al.  Retention predictors of a smoking treatment provided by a public psychosocial unit in Brazil , 2014, International review of psychiatry.

[4]  Jason D. Robinson,et al.  Prequit fMRI responses to pleasant cues and cigarette-related cues predict smoking cessation outcome. , 2014, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[5]  B. Kivell,et al.  The effects of nicotine and tobacco particulate matter on dopamine uptake in the rat brain , 2014, Synapse.

[6]  M. Zvolensky,et al.  Anxiety and depressive symptoms and affective patterns of tobacco withdrawal. , 2013, Drug and alcohol dependence.

[7]  T. Vos,et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[8]  K. Berger,et al.  The relation between sex hormone levels, the androgen receptor CAGn-polymorphism and depression and mortality in older men in a community study , 2013, Psychoneuroendocrinology.

[9]  J. Castaldelli-Maia,et al.  Outcome predictors of smoking cessation treatment provided by an addiction care unit between 2007 and 2010. , 2013, Revista brasileira de psiquiatria.

[10]  E. Stein,et al.  Down-Regulation of Amygdala and Insula Functional Circuits by Varenicline and Nicotine in Abstinent Cigarette Smokers , 2013, Biological Psychiatry.

[11]  A. Nierenberg,et al.  Smoking and suicidality in subjects with major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). , 2013, Journal of affective disorders.

[12]  K. Shulman,et al.  Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression , 2013, CNS Drugs.

[13]  C. Li,et al.  Neural Bases of Pharmacological Treatment of Nicotine Dependence - Insights from Functional Brain Imaging: A Systematic Review , 2013, CNS Drugs.

[14]  D. Mousseau,et al.  An update on amine oxidase inhibitors: Multifaceted drugs , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  Kosha Ruparel,et al.  Brain activity and emotional processing in smokers treated with varenicline , 2013, Addiction biology.

[16]  K. Ma,et al.  Association study of serotonin transporter availability and SLC6A4 gene polymorphisms in patients with major depression , 2013, Psychiatry Research: Neuroimaging.

[17]  Vladyslav Kushnir,et al.  Enhanced smoking cue salience associated with depression severity in nicotine-dependent individuals: a preliminary fMRI study. , 2013, The international journal of neuropsychopharmacology.

[18]  H. Sakai,et al.  Association of menstrual phase with smoking behavior, mood and menstrual phase-associated symptoms among young Japanese women smokers , 2013, BMC Women's Health.

[19]  J. Seibyl,et al.  Sex‐specific differences in GABAA‐benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving , 2013, Addiction biology.

[20]  E. Stein,et al.  Insula’s functional connectivity with ventromedial prefrontal cortex mediates the impact of trait alexithymia on state tobacco craving , 2013, Psychopharmacology.

[21]  G. Northoff.  Gene, brains, and environment—genetic neuroimaging of depression , 2013, Current Opinion in Neurobiology.

[22]  Alan D. Lopez,et al.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[23]  H. Blumberg,et al.  Functional neuroanatomy of bipolar disorder: structure, function, and connectivity in an amygdala–anterior paralimbic neural system , 2012, Bipolar disorders.

[24]  Eric C Donny,et al.  Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction. , 2012, Drug and alcohol dependence.

[25]  Lihong Wang,et al.  Smoking abstinence and depressive symptoms modulate the executive control system during emotional information processing , 2012, Addiction biology.

[26]  J. Seibyl,et al.  Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. , 2012, Archives of general psychiatry.

[27]  Lihong Wang,et al.  Nicotine withdrawal modulates frontal brain function during an affective Stroop task , 2011, Psychopharmacology.

[28]  Alan A. Wilson,et al.  Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. , 2011, Archives of general psychiatry.

[29]  S. Zubrick,et al.  Non-specific psychological distress, smoking status and smoking cessation: United States National Health Interview Survey 2005 , 2011, BMC public health.

[30]  Yihong Yang,et al.  Factors underlying prefrontal and insula structural alterations in smokers , 2011, NeuroImage.

[31]  Y. Mineur,et al.  Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis. , 2010, Trends in pharmacological sciences.

[32]  D. Bertrand,et al.  Neurocircuitry of the nicotinic cholinergic system , 2010, Dialogues in clinical neuroscience.

[33]  Dick J Veltman,et al.  Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study , 2010, Addiction biology.

[34]  Roberto Tatarelli,et al.  Anatomical and functional correlates in major depressive disorder: The contribution of neuroimaging studies , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[35]  Paul M. Grasby,et al.  Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: An [11C]raclopride PET study , 2010, NeuroImage.

[36]  R. Makuch,et al.  GABAA‐benzodiazepine receptor availability in smokers and nonsmokers: Relationship to subsyndromal anxiety and depression , 2009, Synapse.

[37]  M. Chakravarty,et al.  Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression , 2009, Psychological Medicine.

[38]  M. Mandelkern,et al.  Effect of a History of Major Depressive Disorder on Smoking-Induced Dopamine Release , 2009, Biological Psychiatry.

[39]  Sylvain Houle,et al.  Dopaminergic activity in depressed smokers: A positron emission tomography study , 2009, Synapse.

[40]  M. Grégoire,et al.  Cerebral Monoamine Oxidase A Inhibition in Tobacco Smokers Confirmed With PET and [11C]Befloxatone , 2009, Journal of clinical psychopharmacology.

[41]  Jan Booij,et al.  Serotonin transporter binding with [123I]β-CIT SPECT in major depressive disorder versus controls: effect of season and gender , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[42]  Karen J. Ferguson,et al.  Neuroimaging studies of delirium: a systematic review. , 2008, Journal of psychosomatic research.

[43]  J. P. Hamilton,et al.  Neuroimaging and Depression , 2008 .

[44]  J. Detre,et al.  Neural Substrates of Abstinence-Induced Cigarette Cravings in Chronic Smokers , 2007, The Journal of Neuroscience.

[45]  B. Spring,et al.  Double-blind trial of the effects of tryptophan depletion on depression and cerebral blood flow in smokers. , 2004, Addictive behaviors.

[46]  George Bartzokis,et al.  Differences between smokers and nonsmokers in regional gray matter volumes and densities , 2004, Biological Psychiatry.

[47]  H. Mayberg.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. , 2003, British medical bulletin.

[48]  J. Verbalis,et al.  CNS Site of Action and Brainstem Circuitry Responsible for the Intravenous Effects of Nicotine on Gastric Tone , 2002, The Journal of Neuroscience.

[49]  M Fujita,et al.  Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers , 2001, Synapse.

[50]  H. Blumberg,et al.  Hippocampal and anterior cingulate activation deficits in patients with geriatric depression. , 2001, The American journal of psychiatry.

[51]  S Woolhandler,et al.  Smoking and mental illness: A population-based prevalence study. , 2000, JAMA.

[52]  L. Cooper-Patrick,et al.  The Association between Depressive Symptoms and Cigarette Smoking in An Urban Primary Care Sample , 2000, International journal of psychiatry in medicine.

[53]  J. Anthony,et al.  Tobacco smoking and depressed mood in late childhood and early adolescence. , 1999, American journal of public health.

[54]  R. Murray,et al.  Association between variants at the GABAAbeta2, GABAAalpha6 and GABAAgamma2 gene cluster and alcohol dependence in a Scottish population. , 1999, Molecular psychiatry.

[55]  N. Volkow,et al.  Brain monoamine oxidase A inhibition in cigarette smokers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Lajtha,et al.  Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: Role of glutamic acid , 1992, Neurochemical Research.

[57]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[58]  Self-Concept Variables.  Sex Differences in , 2016 .

[59]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[60]  N. Volkow,et al.  Neurocircuitry of Addiction , 2010, Neuropsychopharmacology.

[61]  Arthur W Toga,et al.  Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. , 2004, The American journal of psychiatry.

[62]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[63]  R. Murray,et al.  Association between variants at the GABAAβ2, GABAAα6 and GABAAγ2 gene cluster and alcohol dependence in a Scottish population , 1999, Molecular Psychiatry.